23 min listen
Clinical Trials Part 2: How Are the Results Used?
Clinical Trials Part 2: How Are the Results Used?
ratings:
Length:
29 minutes
Released:
Apr 12, 2018
Format:
Podcast episode
Description
Dr. Dawn Hershman is professor of medicine and epidemiology at Columbia University. She also serves as leader of the Breast Cancer Program at the Herbert Irving Comprehensive Cancer Center at Columbia and is nationally recognized for her expertise in breast cancer treatment, prevention, and survivorship. A member of the Breastcancer.org Professional Advisory Board, Dr. Hershman also has conducted extensive research on breast cancer treatment and quality of life -- she has published more than 250 scientific papers and has received the Advanced Clinical Research Award in Breast Cancer from the American Society of Clinical Oncology and the Advanced Medical Achievement Award from the Avon Foundation. Dr. Hershman is also on the editorial board of the Journal of Clinical Oncology and is an associate editor at the Journal of the National Cancer Institute.
Listen to the podcast to hear Dr. Hershman explain:
how clinical trial results are used
how clinical trial results have changed the standard of care
why factors such as diet or exercise for reducing breast cancer risk are difficult to study in clinical trials
why some trials are stopped early because of good or not-so-good results
Listen to the podcast to hear Dr. Hershman explain:
how clinical trial results are used
how clinical trial results have changed the standard of care
why factors such as diet or exercise for reducing breast cancer risk are difficult to study in clinical trials
why some trials are stopped early because of good or not-so-good results
Released:
Apr 12, 2018
Format:
Podcast episode
Titles in the series (100)
Hope After a Triple-Negative Breast Cancer Diagnosis: Author Patricia Prijatel discusses her book, Surviving Triple-Negative Breast Cancer by Breastcancer.org Podcast